nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—ABCG2—Sorafenib—liver cancer	0.144	0.206	CbGbCtD
Apixaban—ABCG2—Doxorubicin—liver cancer	0.0874	0.125	CbGbCtD
Apixaban—CYP3A5—Sorafenib—liver cancer	0.0798	0.114	CbGbCtD
Apixaban—CYP2C8—Sorafenib—liver cancer	0.0767	0.11	CbGbCtD
Apixaban—CYP2C19—Sorafenib—liver cancer	0.0644	0.0921	CbGbCtD
Apixaban—CYP1A2—Sorafenib—liver cancer	0.0594	0.085	CbGbCtD
Apixaban—CYP2C9—Sorafenib—liver cancer	0.0535	0.0766	CbGbCtD
Apixaban—ABCB1—Sorafenib—liver cancer	0.0519	0.0743	CbGbCtD
Apixaban—ABCB1—Doxorubicin—liver cancer	0.0315	0.0451	CbGbCtD
Apixaban—CYP3A4—Sorafenib—liver cancer	0.0311	0.0445	CbGbCtD
Apixaban—CYP3A4—Doxorubicin—liver cancer	0.0189	0.027	CbGbCtD
Apixaban—Cerebral haemorrhage—Sorafenib—liver cancer	0.004	0.045	CcSEcCtD
Apixaban—Haematoma—Sorafenib—liver cancer	0.00353	0.0396	CcSEcCtD
Apixaban—Blood bilirubin increased—Sorafenib—liver cancer	0.00234	0.0263	CcSEcCtD
Apixaban—Haematochezia—Epirubicin—liver cancer	0.00203	0.0229	CcSEcCtD
Apixaban—Drug hypersensitivity—Epirubicin—liver cancer	0.00203	0.0229	CcSEcCtD
Apixaban—Haematochezia—Doxorubicin—liver cancer	0.00188	0.0212	CcSEcCtD
Apixaban—Drug hypersensitivity—Doxorubicin—liver cancer	0.00188	0.0212	CcSEcCtD
Apixaban—Breast disorder—Sorafenib—liver cancer	0.00145	0.0163	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.00145	0.0163	CcSEcCtD
Apixaban—Gingival bleeding—Epirubicin—liver cancer	0.00144	0.0162	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Sorafenib—liver cancer	0.00142	0.016	CcSEcCtD
Apixaban—Transaminases increased—Epirubicin—liver cancer	0.00135	0.0151	CcSEcCtD
Apixaban—Gingival bleeding—Doxorubicin—liver cancer	0.00134	0.015	CcSEcCtD
Apixaban—Transaminases increased—Doxorubicin—liver cancer	0.00125	0.014	CcSEcCtD
Apixaban—Haematemesis—Epirubicin—liver cancer	0.00118	0.0133	CcSEcCtD
Apixaban—Hepatobiliary disease—Sorafenib—liver cancer	0.00117	0.0132	CcSEcCtD
Apixaban—Epistaxis—Sorafenib—liver cancer	0.00117	0.0131	CcSEcCtD
Apixaban—Haemoglobin—Sorafenib—liver cancer	0.00112	0.0126	CcSEcCtD
Apixaban—Haemorrhage—Sorafenib—liver cancer	0.00111	0.0125	CcSEcCtD
Apixaban—Haemoptysis—Epirubicin—liver cancer	0.00111	0.0124	CcSEcCtD
Apixaban—Vaginal haemorrhage—Epirubicin—liver cancer	0.00111	0.0124	CcSEcCtD
Apixaban—Urinary tract disorder—Sorafenib—liver cancer	0.0011	0.0124	CcSEcCtD
Apixaban—Connective tissue disorder—Sorafenib—liver cancer	0.00109	0.0123	CcSEcCtD
Apixaban—Urethral disorder—Sorafenib—liver cancer	0.00109	0.0123	CcSEcCtD
Apixaban—Haematemesis—Doxorubicin—liver cancer	0.00109	0.0123	CcSEcCtD
Apixaban—Vaginal haemorrhage—Doxorubicin—liver cancer	0.00102	0.0115	CcSEcCtD
Apixaban—Haemoptysis—Doxorubicin—liver cancer	0.00102	0.0115	CcSEcCtD
Apixaban—Angiopathy—Sorafenib—liver cancer	0.00101	0.0114	CcSEcCtD
Apixaban—Immune system disorder—Sorafenib—liver cancer	0.00101	0.0113	CcSEcCtD
Apixaban—Mediastinal disorder—Sorafenib—liver cancer	0.001	0.0113	CcSEcCtD
Apixaban—Petechiae—Epirubicin—liver cancer	0.000995	0.0112	CcSEcCtD
Apixaban—Petechiae—Doxorubicin—liver cancer	0.000921	0.0104	CcSEcCtD
Apixaban—Rectal haemorrhage—Epirubicin—liver cancer	0.000907	0.0102	CcSEcCtD
Apixaban—Anaemia—Sorafenib—liver cancer	0.000895	0.0101	CcSEcCtD
Apixaban—Syncope—Sorafenib—liver cancer	0.000869	0.00977	CcSEcCtD
Apixaban—Blood bilirubin increased—Epirubicin—liver cancer	0.000866	0.00973	CcSEcCtD
Apixaban—Loss of consciousness—Sorafenib—liver cancer	0.000851	0.00957	CcSEcCtD
Apixaban—Rectal haemorrhage—Doxorubicin—liver cancer	0.000839	0.00943	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000819	0.00921	CcSEcCtD
Apixaban—Blood bilirubin increased—Doxorubicin—liver cancer	0.000801	0.00901	CcSEcCtD
Apixaban—Melaena—Epirubicin—liver cancer	0.0008	0.00899	CcSEcCtD
Apixaban—Anaphylactic shock—Sorafenib—liver cancer	0.000791	0.00889	CcSEcCtD
Apixaban—Shock—Sorafenib—liver cancer	0.000778	0.00875	CcSEcCtD
Apixaban—Nervous system disorder—Sorafenib—liver cancer	0.000775	0.00872	CcSEcCtD
Apixaban—Thrombocytopenia—Sorafenib—liver cancer	0.000774	0.0087	CcSEcCtD
Apixaban—Skin disorder—Sorafenib—liver cancer	0.000768	0.00863	CcSEcCtD
Apixaban—Ecchymosis—Epirubicin—liver cancer	0.00074	0.00832	CcSEcCtD
Apixaban—Melaena—Doxorubicin—liver cancer	0.00074	0.00832	CcSEcCtD
Apixaban—Ecchymosis—Doxorubicin—liver cancer	0.000685	0.0077	CcSEcCtD
Apixaban—Diabetes mellitus—Epirubicin—liver cancer	0.000683	0.00768	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.000683	0.00768	CcSEcCtD
Apixaban—Gastrointestinal disorder—Sorafenib—liver cancer	0.000683	0.00767	CcSEcCtD
Apixaban—Diabetes mellitus—Doxorubicin—liver cancer	0.000632	0.00711	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.000632	0.00711	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000594	0.00668	CcSEcCtD
Apixaban—Hypersensitivity—Sorafenib—liver cancer	0.000582	0.00655	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00055	0.00618	CcSEcCtD
Apixaban—Liver function test abnormal—Epirubicin—liver cancer	0.000549	0.00617	CcSEcCtD
Apixaban—Breast disorder—Epirubicin—liver cancer	0.000537	0.00604	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000535	0.00602	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000524	0.00589	CcSEcCtD
Apixaban—Dizziness—Sorafenib—liver cancer	0.000523	0.00588	CcSEcCtD
Apixaban—Liver function test abnormal—Doxorubicin—liver cancer	0.000508	0.00571	CcSEcCtD
Apixaban—Rash—Sorafenib—liver cancer	0.000498	0.0056	CcSEcCtD
Apixaban—Dermatitis—Sorafenib—liver cancer	0.000498	0.0056	CcSEcCtD
Apixaban—Breast disorder—Doxorubicin—liver cancer	0.000497	0.00559	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000495	0.00557	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000485	0.00545	CcSEcCtD
Apixaban—Nausea—Sorafenib—liver cancer	0.00047	0.00528	CcSEcCtD
Apixaban—Haematuria—Epirubicin—liver cancer	0.000437	0.00491	CcSEcCtD
Apixaban—Hepatobiliary disease—Epirubicin—liver cancer	0.000433	0.00487	CcSEcCtD
Apixaban—Epistaxis—Epirubicin—liver cancer	0.000432	0.00486	CcSEcCtD
Apixaban—Haemoglobin—Epirubicin—liver cancer	0.000413	0.00465	CcSEcCtD
Apixaban—Haemorrhage—Epirubicin—liver cancer	0.000411	0.00462	CcSEcCtD
Apixaban—Urinary tract disorder—Epirubicin—liver cancer	0.000406	0.00457	CcSEcCtD
Apixaban—Haematuria—Doxorubicin—liver cancer	0.000404	0.00454	CcSEcCtD
Apixaban—Connective tissue disorder—Epirubicin—liver cancer	0.000404	0.00454	CcSEcCtD
Apixaban—Urethral disorder—Epirubicin—liver cancer	0.000403	0.00453	CcSEcCtD
Apixaban—Hepatobiliary disease—Doxorubicin—liver cancer	0.000401	0.00451	CcSEcCtD
Apixaban—Epistaxis—Doxorubicin—liver cancer	0.0004	0.0045	CcSEcCtD
Apixaban—Eye disorder—Epirubicin—liver cancer	0.000384	0.00432	CcSEcCtD
Apixaban—Haemoglobin—Doxorubicin—liver cancer	0.000382	0.0043	CcSEcCtD
Apixaban—Haemorrhage—Doxorubicin—liver cancer	0.000381	0.00428	CcSEcCtD
Apixaban—Urinary tract disorder—Doxorubicin—liver cancer	0.000376	0.00423	CcSEcCtD
Apixaban—Connective tissue disorder—Doxorubicin—liver cancer	0.000374	0.0042	CcSEcCtD
Apixaban—Angiopathy—Epirubicin—liver cancer	0.000373	0.0042	CcSEcCtD
Apixaban—Urethral disorder—Doxorubicin—liver cancer	0.000373	0.00419	CcSEcCtD
Apixaban—Immune system disorder—Epirubicin—liver cancer	0.000371	0.00418	CcSEcCtD
Apixaban—Mediastinal disorder—Epirubicin—liver cancer	0.000371	0.00417	CcSEcCtD
Apixaban—Eye disorder—Doxorubicin—liver cancer	0.000356	0.004	CcSEcCtD
Apixaban—Angiopathy—Doxorubicin—liver cancer	0.000345	0.00388	CcSEcCtD
Apixaban—Immune system disorder—Doxorubicin—liver cancer	0.000344	0.00386	CcSEcCtD
Apixaban—Mediastinal disorder—Doxorubicin—liver cancer	0.000343	0.00386	CcSEcCtD
Apixaban—Anaemia—Epirubicin—liver cancer	0.000331	0.00372	CcSEcCtD
Apixaban—Syncope—Epirubicin—liver cancer	0.000321	0.00361	CcSEcCtD
Apixaban—Loss of consciousness—Epirubicin—liver cancer	0.000315	0.00354	CcSEcCtD
Apixaban—Anaemia—Doxorubicin—liver cancer	0.000306	0.00344	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000303	0.0034	CcSEcCtD
Apixaban—Syncope—Doxorubicin—liver cancer	0.000297	0.00334	CcSEcCtD
Apixaban—Anaphylactic shock—Epirubicin—liver cancer	0.000292	0.00329	CcSEcCtD
Apixaban—Loss of consciousness—Doxorubicin—liver cancer	0.000291	0.00327	CcSEcCtD
Apixaban—Shock—Epirubicin—liver cancer	0.000287	0.00323	CcSEcCtD
Apixaban—Nervous system disorder—Epirubicin—liver cancer	0.000287	0.00322	CcSEcCtD
Apixaban—Thrombocytopenia—Epirubicin—liver cancer	0.000286	0.00322	CcSEcCtD
Apixaban—Skin disorder—Epirubicin—liver cancer	0.000284	0.00319	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00028	0.00315	CcSEcCtD
Apixaban—Hypotension—Epirubicin—liver cancer	0.000273	0.00307	CcSEcCtD
Apixaban—Anaphylactic shock—Doxorubicin—liver cancer	0.00027	0.00304	CcSEcCtD
Apixaban—Shock—Doxorubicin—liver cancer	0.000266	0.00299	CcSEcCtD
Apixaban—Nervous system disorder—Doxorubicin—liver cancer	0.000265	0.00298	CcSEcCtD
Apixaban—Thrombocytopenia—Doxorubicin—liver cancer	0.000265	0.00298	CcSEcCtD
Apixaban—Skin disorder—Doxorubicin—liver cancer	0.000263	0.00295	CcSEcCtD
Apixaban—Hypotension—Doxorubicin—liver cancer	0.000253	0.00284	CcSEcCtD
Apixaban—Gastrointestinal disorder—Epirubicin—liver cancer	0.000252	0.00284	CcSEcCtD
Apixaban—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000233	0.00262	CcSEcCtD
Apixaban—Hypersensitivity—Epirubicin—liver cancer	0.000215	0.00242	CcSEcCtD
Apixaban—Hypersensitivity—Doxorubicin—liver cancer	0.000199	0.00224	CcSEcCtD
Apixaban—Dizziness—Epirubicin—liver cancer	0.000193	0.00217	CcSEcCtD
Apixaban—Rash—Epirubicin—liver cancer	0.000184	0.00207	CcSEcCtD
Apixaban—Dermatitis—Epirubicin—liver cancer	0.000184	0.00207	CcSEcCtD
Apixaban—Dizziness—Doxorubicin—liver cancer	0.000179	0.00201	CcSEcCtD
Apixaban—Nausea—Epirubicin—liver cancer	0.000174	0.00195	CcSEcCtD
Apixaban—Rash—Doxorubicin—liver cancer	0.00017	0.00192	CcSEcCtD
Apixaban—Dermatitis—Doxorubicin—liver cancer	0.00017	0.00191	CcSEcCtD
Apixaban—Nausea—Doxorubicin—liver cancer	0.000161	0.00181	CcSEcCtD
Apixaban—ABCG2—Metabolism—CYCS—liver cancer	3.27e-05	0.000154	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—TAT—liver cancer	3.26e-05	0.000153	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NR1H4—liver cancer	3.24e-05	0.000152	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—GOT1—liver cancer	3.2e-05	0.000151	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—GGT1—liver cancer	3.2e-05	0.000151	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.2e-05	0.000151	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTA4—liver cancer	3.19e-05	0.00015	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ALDOB—liver cancer	3.19e-05	0.00015	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTA3—liver cancer	3.18e-05	0.00015	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	3.14e-05	0.000148	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	3.13e-05	0.000148	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.12e-05	0.000147	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTA4—liver cancer	3.11e-05	0.000147	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTA2—liver cancer	3.11e-05	0.000146	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.11e-05	0.000146	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—HPGDS—liver cancer	3.07e-05	0.000144	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CRABP1—liver cancer	3.04e-05	0.000143	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTA2—liver cancer	3.03e-05	0.000143	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTA1—liver cancer	3e-05	0.000141	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—NAT2—liver cancer	2.97e-05	0.00014	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTA1—liver cancer	2.93e-05	0.000138	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	2.93e-05	0.000138	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTA4—liver cancer	2.91e-05	0.000137	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	2.9e-05	0.000137	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—NAT2—liver cancer	2.9e-05	0.000136	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—GSTP1—liver cancer	2.88e-05	0.000136	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GLUL—liver cancer	2.87e-05	0.000135	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CPT1B—liver cancer	2.87e-05	0.000135	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.85e-05	0.000134	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ALDOB—liver cancer	2.84e-05	0.000134	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.84e-05	0.000134	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—HMOX1—liver cancer	2.84e-05	0.000134	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTA2—liver cancer	2.84e-05	0.000134	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ALDOB—liver cancer	2.78e-05	0.000131	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NR1H4—liver cancer	2.76e-05	0.00013	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.74e-05	0.000129	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTA1—liver cancer	2.74e-05	0.000129	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PSMA4—liver cancer	2.73e-05	0.000129	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PSMD10—liver cancer	2.73e-05	0.000129	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTA3—liver cancer	2.72e-05	0.000128	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CRABP1—liver cancer	2.71e-05	0.000128	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NAT2—liver cancer	2.7e-05	0.000127	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	2.67e-05	0.000126	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GOT2—liver cancer	2.66e-05	0.000125	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—HPGDS—liver cancer	2.66e-05	0.000125	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CRABP1—liver cancer	2.65e-05	0.000125	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	2.65e-05	0.000125	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—GSTM1—liver cancer	2.64e-05	0.000125	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.64e-05	0.000124	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.6e-05	0.000123	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALDOB—liver cancer	2.59e-05	0.000122	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.58e-05	0.000122	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CYP1A1—liver cancer	2.51e-05	0.000118	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYP2E1—liver cancer	2.5e-05	0.000118	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTA4—liver cancer	2.49e-05	0.000117	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CRABP1—liver cancer	2.47e-05	0.000117	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.44e-05	0.000115	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.43e-05	0.000114	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTA2—liver cancer	2.42e-05	0.000114	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.41e-05	0.000113	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.37e-05	0.000112	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—HPGDS—liver cancer	2.37e-05	0.000112	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PSMA4—liver cancer	2.37e-05	0.000112	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PSMD10—liver cancer	2.37e-05	0.000112	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.36e-05	0.000111	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYCS—liver cancer	2.34e-05	0.00011	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTA1—liver cancer	2.34e-05	0.00011	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—MTHFR—liver cancer	2.34e-05	0.00011	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—HPGDS—liver cancer	2.31e-05	0.000109	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NAT2—liver cancer	2.31e-05	0.000109	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GOT2—liver cancer	2.3e-05	0.000109	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GGT1—liver cancer	2.3e-05	0.000108	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GOT1—liver cancer	2.3e-05	0.000108	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PPARA—liver cancer	2.29e-05	0.000108	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PIK3CA—liver cancer	2.28e-05	0.000107	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.23e-05	0.000105	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.22e-05	0.000105	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALDOB—liver cancer	2.22e-05	0.000104	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GLUL—liver cancer	2.21e-05	0.000104	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CPT1B—liver cancer	2.21e-05	0.000104	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.18e-05	0.000103	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP2E1—liver cancer	2.17e-05	0.000102	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—HPGDS—liver cancer	2.16e-05	0.000102	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.15e-05	0.000101	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.15e-05	0.000101	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NR1H4—liver cancer	2.13e-05	0.000101	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.12e-05	9.99e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CRABP1—liver cancer	2.11e-05	9.96e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PSMD10—liver cancer	2.11e-05	9.96e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PSMA4—liver cancer	2.11e-05	9.96e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTA3—liver cancer	2.1e-05	9.88e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.1e-05	9.88e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PSMD10—liver cancer	2.06e-05	9.72e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PSMA4—liver cancer	2.06e-05	9.72e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GSTP1—liver cancer	2.06e-05	9.71e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GOT2—liver cancer	2.06e-05	9.69e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—HMOX1—liver cancer	2.03e-05	9.58e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYCS—liver cancer	2.03e-05	9.55e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GOT2—liver cancer	2.01e-05	9.45e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GOT1—liver cancer	1.99e-05	9.37e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GGT1—liver cancer	1.99e-05	9.37e-05	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	1.97e-05	9.27e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CG—liver cancer	1.96e-05	9.25e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.96e-05	9.22e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP2E1—liver cancer	1.93e-05	9.11e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.93e-05	9.11e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PSMD10—liver cancer	1.93e-05	9.08e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PSMA4—liver cancer	1.93e-05	9.08e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTA4—liver cancer	1.92e-05	9.04e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.9e-05	8.97e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PPARG—liver cancer	1.9e-05	8.93e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GSTM1—liver cancer	1.89e-05	8.93e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP2E1—liver cancer	1.89e-05	8.89e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GOT2—liver cancer	1.87e-05	8.83e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.87e-05	8.82e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTA2—liver cancer	1.87e-05	8.81e-05	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—AKT1—liver cancer	1.86e-05	8.78e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—HPGDS—liver cancer	1.85e-05	8.7e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.84e-05	8.65e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYCS—liver cancer	1.81e-05	8.52e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTA1—liver cancer	1.8e-05	8.5e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYP1A1—liver cancer	1.8e-05	8.46e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTP1—liver cancer	1.79e-05	8.41e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NAT2—liver cancer	1.78e-05	8.4e-05	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.78e-05	8.38e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GGT1—liver cancer	1.77e-05	8.36e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GOT1—liver cancer	1.77e-05	8.36e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYCS—liver cancer	1.77e-05	8.32e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP2E1—liver cancer	1.76e-05	8.3e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—HMOX1—liver cancer	1.76e-05	8.3e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GGT1—liver cancer	1.73e-05	8.16e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GOT1—liver cancer	1.73e-05	8.16e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CD—liver cancer	1.73e-05	8.13e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALDOB—liver cancer	1.71e-05	8.06e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.71e-05	8.04e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ALB—liver cancer	1.7e-05	8.03e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—MTHFR—liver cancer	1.67e-05	7.89e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.67e-05	7.88e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.65e-05	7.78e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYCS—liver cancer	1.65e-05	7.77e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PSMA4—liver cancer	1.65e-05	7.76e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PSMD10—liver cancer	1.65e-05	7.76e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PPARA—liver cancer	1.64e-05	7.74e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTM1—liver cancer	1.64e-05	7.73e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CRABP1—liver cancer	1.63e-05	7.69e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GGT1—liver cancer	1.62e-05	7.62e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GOT1—liver cancer	1.62e-05	7.62e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GOT2—liver cancer	1.6e-05	7.55e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTP1—liver cancer	1.59e-05	7.51e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—HMOX1—liver cancer	1.57e-05	7.41e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTP1—liver cancer	1.56e-05	7.33e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP1A1—liver cancer	1.56e-05	7.33e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—HMOX1—liver cancer	1.53e-05	7.23e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP2E1—liver cancer	1.51e-05	7.1e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CB—liver cancer	1.5e-05	7.09e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTM1—liver cancer	1.47e-05	6.9e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.46e-05	6.87e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTP1—liver cancer	1.45e-05	6.85e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—MTHFR—liver cancer	1.45e-05	6.83e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—HMOX1—liver cancer	1.43e-05	6.75e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTM1—liver cancer	1.43e-05	6.74e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HPGDS—liver cancer	1.43e-05	6.72e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PPARA—liver cancer	1.42e-05	6.7e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYCS—liver cancer	1.41e-05	6.64e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CG—liver cancer	1.41e-05	6.63e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP1A1—liver cancer	1.39e-05	6.54e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GOT1—liver cancer	1.38e-05	6.51e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GGT1—liver cancer	1.38e-05	6.51e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PPARG—liver cancer	1.36e-05	6.4e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP1A1—liver cancer	1.36e-05	6.39e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTM1—liver cancer	1.34e-05	6.29e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—MTHFR—liver cancer	1.29e-05	6.1e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.28e-05	6.02e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PSMD10—liver cancer	1.27e-05	5.99e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PSMA4—liver cancer	1.27e-05	5.99e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PPARA—liver cancer	1.27e-05	5.98e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP1A1—liver cancer	1.27e-05	5.97e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—MTHFR—liver cancer	1.26e-05	5.95e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTP1—liver cancer	1.24e-05	5.85e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PPARA—liver cancer	1.24e-05	5.84e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CD—liver cancer	1.24e-05	5.83e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GOT2—liver cancer	1.24e-05	5.82e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—HMOX1—liver cancer	1.23e-05	5.77e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ALB—liver cancer	1.22e-05	5.75e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CG—liver cancer	1.22e-05	5.74e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—MTHFR—liver cancer	1.18e-05	5.56e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PPARG—liver cancer	1.18e-05	5.54e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP2E1—liver cancer	1.16e-05	5.48e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PPARA—liver cancer	1.16e-05	5.46e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTM1—liver cancer	1.14e-05	5.38e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.14e-05	5.38e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CG—liver cancer	1.09e-05	5.12e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYCS—liver cancer	1.09e-05	5.12e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP1A1—liver cancer	1.08e-05	5.1e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CB—liver cancer	1.08e-05	5.08e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CD—liver cancer	1.07e-05	5.05e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GGT1—liver cancer	1.07e-05	5.03e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GOT1—liver cancer	1.07e-05	5.03e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CG—liver cancer	1.06e-05	5e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ALB—liver cancer	1.06e-05	4.98e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PPARG—liver cancer	1.05e-05	4.95e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.04e-05	4.9e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PPARG—liver cancer	1.02e-05	4.83e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—MTHFR—liver cancer	1.01e-05	4.75e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CG—liver cancer	9.92e-06	4.67e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PPARA—liver cancer	9.9e-06	4.66e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTP1—liver cancer	9.59e-06	4.52e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PPARG—liver cancer	9.57e-06	4.51e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CD—liver cancer	9.56e-06	4.51e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HMOX1—liver cancer	9.45e-06	4.45e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ALB—liver cancer	9.44e-06	4.45e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CB—liver cancer	9.34e-06	4.4e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CD—liver cancer	9.33e-06	4.4e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ALB—liver cancer	9.21e-06	4.34e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CA—liver cancer	9.17e-06	4.32e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.89e-06	4.19e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTM1—liver cancer	8.81e-06	4.15e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CD—liver cancer	8.72e-06	4.11e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALB—liver cancer	8.61e-06	4.06e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CG—liver cancer	8.48e-06	3.99e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP1A1—liver cancer	8.35e-06	3.93e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CB—liver cancer	8.34e-06	3.93e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PPARG—liver cancer	8.18e-06	3.85e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CB—liver cancer	8.14e-06	3.83e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—MTHFR—liver cancer	7.79e-06	3.67e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PPARA—liver cancer	7.64e-06	3.6e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CB—liver cancer	7.6e-06	3.58e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—AKT1—liver cancer	7.49e-06	3.53e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CD—liver cancer	7.45e-06	3.51e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALB—liver cancer	7.36e-06	3.47e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CA—liver cancer	6.57e-06	3.1e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CG—liver cancer	6.54e-06	3.08e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CB—liver cancer	6.49e-06	3.06e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PPARG—liver cancer	6.31e-06	2.97e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CD—liver cancer	5.75e-06	2.71e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CA—liver cancer	5.69e-06	2.68e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALB—liver cancer	5.68e-06	2.67e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—AKT1—liver cancer	5.37e-06	2.53e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CA—liver cancer	5.08e-06	2.39e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CB—liver cancer	5.01e-06	2.36e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CA—liver cancer	4.96e-06	2.34e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—AKT1—liver cancer	4.65e-06	2.19e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CA—liver cancer	4.63e-06	2.18e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—AKT1—liver cancer	4.15e-06	1.96e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—AKT1—liver cancer	4.05e-06	1.91e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CA—liver cancer	3.96e-06	1.87e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—AKT1—liver cancer	3.78e-06	1.78e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—AKT1—liver cancer	3.23e-06	1.52e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CA—liver cancer	3.06e-06	1.44e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—AKT1—liver cancer	2.5e-06	1.18e-05	CbGpPWpGaD
